(Q44924458)

7 December 2017

title

Prostate Specific Antigen Levels after Definitive Irradiation for Carcinoma of the Prostate (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

4 November 2022

author name string

P. F. Schellhammer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707987

4 November 2022

S. M. Schlossberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707987

4 November 2022

A. M. el-Mahdi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707987

4 November 2022

G. L. Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707987

4 November 2022

D. N. Brassil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707987

4 November 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

7 December 2017

https://api.elsevier.com/content/article/PII:S0022534717385142?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

https://api.elsevier.com/content/article/PII:S0022534717385142?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2938514-2

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

4 November 2022

1 reference

7 December 2017

volume

145

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

1008-10; discussion 1010-1

1 reference

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

7 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Prostate-specific antigen in management of prostatic carcinoma

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

4 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice

4 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38514-2

4 November 2022

Identifiers

1 reference

7 December 2017

1 reference